Quantifying the Effect of Consent for High-Kidney Donor Profile Index Deceased Donor Transplants in the United States.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
13 Feb 2024
Historique:
received: 19 10 2023
accepted: 06 02 2024
medline: 13 2 2024
pubmed: 13 2 2024
entrez: 13 2 2024
Statut: aheadofprint

Résumé

Despite known benefits of kidney transplantation, including transplantation from donors with increased risk factors, many waitlisted candidates die prior to transplantation. Consent to receive donor kidneys with lower expected survival (e.g. kidney donor profile index [KDPI]>85%) is typically obtained at waitlist placement. The presumed benefit of consent to receive high-KDPI donor kidneys is increased likelihood and timeliness of donor offers for transplantation. However, the specific impact of consent on access to transplantation is unclear. Our aims were to evaluate the characteristics of candidates consenting to high-KDPI donor kidneys and the likelihood of receiving a deceased donor transplant (DDTX) over time based on consent. We used national Scientific Registry of Transplant Recipients data between 2015 and 2022(n=213,364). We evaluated the likelihood of consent using multivariable logistic models and time to DDTX with cumulative incidence plots accounting for competing risks and multivariable Cox models. Overall, high-KDPI consent was 41%, which was higher among candidates who were older, Black or Hispanic, had higher BMI, were diabetic, had vascular disease, and 12-48 months pre-listing dialysis time, with significant center-level variation. High-KDPI consent was associated with higher rates of DDTX(Adjusted Hazard Ratio=1.15,95% Confidence Interval=1.13,1.17) with no difference in likelihood of DDTX from donors with KDPI<85%. The effect of high-KDPI consent on higher rates of DDTx was higher among candidates ages >60 years and diabetic candidates and variable based on center characteristics. There is significant variation of consent for high-KDPI donor kidneys and higher likelihood of transplantation associated with consent.

Sections du résumé

BACKGROUND BACKGROUND
Despite known benefits of kidney transplantation, including transplantation from donors with increased risk factors, many waitlisted candidates die prior to transplantation. Consent to receive donor kidneys with lower expected survival (e.g. kidney donor profile index [KDPI]>85%) is typically obtained at waitlist placement. The presumed benefit of consent to receive high-KDPI donor kidneys is increased likelihood and timeliness of donor offers for transplantation. However, the specific impact of consent on access to transplantation is unclear. Our aims were to evaluate the characteristics of candidates consenting to high-KDPI donor kidneys and the likelihood of receiving a deceased donor transplant (DDTX) over time based on consent.
METHODS METHODS
We used national Scientific Registry of Transplant Recipients data between 2015 and 2022(n=213,364). We evaluated the likelihood of consent using multivariable logistic models and time to DDTX with cumulative incidence plots accounting for competing risks and multivariable Cox models.
RESULTS RESULTS
Overall, high-KDPI consent was 41%, which was higher among candidates who were older, Black or Hispanic, had higher BMI, were diabetic, had vascular disease, and 12-48 months pre-listing dialysis time, with significant center-level variation. High-KDPI consent was associated with higher rates of DDTX(Adjusted Hazard Ratio=1.15,95% Confidence Interval=1.13,1.17) with no difference in likelihood of DDTX from donors with KDPI<85%. The effect of high-KDPI consent on higher rates of DDTx was higher among candidates ages >60 years and diabetic candidates and variable based on center characteristics.
CONCLUSIONS CONCLUSIONS
There is significant variation of consent for high-KDPI donor kidneys and higher likelihood of transplantation associated with consent.

Identifiants

pubmed: 38347668
doi: 10.1681/ASN.0000000000000318
pii: 00001751-990000000-00258
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 by the American Society of Nephrology.

Auteurs

Jesse D Schold (JD)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Kendra D Conzen (KD)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

James Cooper (J)

Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Susana Arrigain (S)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Rocio Lopez (R)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Sumit Mohan (S)

Department of Medicine, Columbia University, New York, New York.
Department of Epidemiology, Columbia University, New York, New York.

S Ali Husain (SA)

Department of Medicine, Columbia University, New York, New York.

Anne M Huml (AM)

Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio.

Peter T Kennealey (PT)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Bruce Kaplan (B)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Elizabeth A Pomfret (EA)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Classifications MeSH